There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of these life saving drugs. However, these possibilities are opposed by some scientific challenges and unanswered questions.
This report elaborates the market size, market characteristics, and market growth of the Biosimilars-On-Biologics industry, and breaks down according to the type, application, and consumption area of Biosimilars-On-Biologics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biosimilars-On-Biologics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Biosimilars-On-Biologics market covered in Chapter 13:
Biogen Idec
3SBio
Ranbaxy Laboratories
Elan Corporation
CCL Pharmaceuticals
Sandoz
Amphastar Pharmaceuticals
Dr. Reddys Laboratories
Mitsubishi Tanabe Pharma Corporation
Johnson & Johnson
Genentech
Axicorp
Alexion Pharmaceuticals
Avesta Biotherapeutics and Research (ABRPL)
Avesthagen
Abbott
Cipla
Astra Zeneca
CinnaGen
Abraxis BioScience
Zenotech
Bristol-Myers Squibb
GlaxoSmithKline (GSK)
In Chapter 6, on the basis of types, the Biosimilars-On-Biologics market from 2015 to 2025 is primarily split into:
Peptides
Recombinant Glycosylated Proteins
Recombinant Non-glycosylated Proteins
Others
In Chapter 7, on the basis of applications, the Biosimilars-On-Biologics market from 2015 to 2025 covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
